生物标志物:它们在严重的社区肺炎中有用吗?
Pedro Póvoa1,2,3, Melissa Pitrowsky4, Gonçalo Guerreiro3
1NOVA Medical School, Centre for Integrated Research in Health, New University of Lisbon, Lisbon, Portugal.
Seminars in respiratory and critical care medicine
|January 10, 2024
概括
诊断严重的社区性肺炎 (CAP) 是很困难的. 生物标志物有望改善CAP的诊断和管理,但需要更多的研究才能获得最佳的临床使用.
科学领域:
- 传染性疾病 传染性疾病
- 临床诊断 临床诊断 临床诊断
- 生物标志物研究 生物标志物研究
背景情况:
- 社区获得性肺炎 (CAP) 是一种常见的,严重的感染,具有诊断挑战.
- 目前用于严重CAP (sCAP) 的诊断方法 (临床,放射,微生物) 在准确性和及时性方面存在局限性.
- 生物标志物为改善诊断,风险分层和监测CAP提供了潜力.
研究的目的:
- 审查生物标志物在CAP诊断和管理中的作用,特别是严重病例.
- 评估生物标志物的实用性,作为临床和放射学发现的辅助.
- 确定有前途的生物标志物和未来 CAP 管理研究领域.
主要方法:
- 对CAP诊断和管理的生物标志物研究的文献综述.
- 对不同患者群体 (初级保健,急诊,严重CAP) 生物标志物表现的证据分析.
- 专注于生物标志物,如C反应蛋白 (CRP) 和前素 (PCT).
主要成果:
- 生物标志物可以帮助诊断CAP和监测治疗反应.
- 对生物标志物的证据在一般的CAP种群中比在sCAP中更为广泛.
- CRP和PCT是研究最多的生物标志物,显示出显著的临床效用.
- 生物标志物可以帮助区分病毒性肺炎,并评估疾病的严重程度.
结论:
- 生物标志物提供了有价值的辅助信息,用于CAP管理中的临床决策.
- 需要进一步的研究和验证,以确定最佳的生物标志物使用和临床效用,特别是在严重的CAP中.
- 生物标志物可以提高CAP患者的风险分层和治疗监测.
相关概念视频
01:30Pneumonia III: Complications and Assessment
227
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
227
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
159
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
159
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
93
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
93
01:28Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331
01:30Pneumonia I: Introduction
239
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
239